Financials

News Ideas Technicals Forecast

SYRE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Spyre Therapeutics, Inc.

Total assets of SYRE for Q1 24 is 487.60 M USD, 42.63% more than the previous Q4 23. And total liabilities increased by 112.45% in Q1 24 to 335.33 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—